KaraLeanneBickhamMD
Pediatric Infectious Disease • Rahway, NJClinical Director, Vaccine Late Stage Development Merck Research Laboratories
Dr. Bickham is on Doximity
As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
126 E Lincoln Ave
Rahway, NJ 07065Phone(732) 894-1884
- Is this information wrong?
Education & Training
New York Presbyterian Hospital - Cornell CampusResidency, Pediatrics, 1994 - 1997
University of Texas Southwestern Medical SchoolClass of 1994
Certifications & Licensure
NY State Medical License 1997 - 2017- American Board of Pediatrics Pediatric Infectious Diseases
Publications & Presentations
PubMed
- Pharmacokinetics/pharmacodynamics, safety, and tolerability of fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in pediatric cancer patients.Jaume Mora, Miguel Valero, Cara DiCristina, Mandy Jin, Anne Chain, Kara Bickham> ;Pediatric Blood & Cancer. 2019 Jun 1
- Airway CD8(+) T Cells Are Associated with Lung Injury during Infant Viral Respiratory Tract Infection.Thomas J. Connors, Thyyar M. Ravindranath, Kara L. Bickham, Claire L. Gordon, Feifan Zhang, Bruce Levin, John S. Baird, Donna L. Farber> ;American Journal of Respiratory Cell and Molecular Biology. 2016 Jun 1
- Lung niches for the generation and maintenance of tissue-resident memory T cellsDamian Turner, Kara L. Bickham, Joseph J.C. Thome, C. Y. Kim, Frank D'Ovidio, E. J. Wherry, Donna L. Farber> ;Mucosal Immunology. 2014 May 1
- Join now to see all
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
